National Breast Cancer and Lymphedema Registry



Status:Terminated
Conditions:Breast Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:7/1/2018
Start Date:September 12, 2011
End Date:March 2, 2018

Use our guide to learn which trials are right for you!

The purpose of the National Breast Cancer Lymphedema Registry is to collect health
information in order to study the lymphedema as a complication of breast cancer treatment.
The investigators hope to learn whether early diagnosis will help to prevent lymphedema or,
if it does occur, to reduce the severity.

Historically, breast cancer-associated lymphedema has been relatively ignored, with
mis-diagnosis, late diagnosis, and failure to treat. The condition has a measurable,
substantial impact on patient function and perceived quality of life (QOL). Recent pilot
studies suggest that interventions that are designed to facilitate early diagnosis and
preventive strategies have a major impact on the incidence and severity of disease burden.
This registry is designed to prospectively capture the relevant data to document the impact
of preemptive diagnostic and treatment strategies.

Inclusion Criteria:

- Breast cancer survivorship

Exclusion Criteria:

- Age < 18 years old
We found this trial at
1
site
291 Campus Dr
Stanford, California 94305
(650) 725-3900
Stanford University School of Medicine Vast in both its physical scale and its impact on...
?
mi
from
Stanford, CA
Click here to add this to my saved trials